SCHEMBL26258152

SCHEMBL26258152

COc1ncc(F)c(N2CC3CC3C2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
SLC9A1 P19634 2/20 0.36
SLC9A2 Q9UBY0 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2D6 P10635 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
ACACB O00763 5/20 0.33
ALDH1A1 P00352 4/20 0.33
HSD17B10 Q99714 3/20 0.33
CYP1A2 P05177 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26257380 0.76 SMN1; SMN2 (0.58) SMN1; SMN2KDM4EALDH1A1HSD17B10KMT2A
SCHEMBL24920804 0.71 PDK2 (0.37) PDK2SMN1; SMN2SLC9A1SLC9A2NPC1
SCHEMBL19649880 0.68 JAK1 (0.66)
SCHEMBL24920900 0.68 PDK2 (0.35) PDK2SLC9A1SLC9A2CYP3A4CYP2C9
SCHEMBL21905028 0.67 CYP1A2 (0.37) CYP3A4CYP2C9ALDH1A1HSD17B10CYP1A2
SCHEMBL24920813 0.67 PDK2 (0.37) PDK2SLC9A1SLC9A2CYP3A4CYP2C9
SCHEMBL24920808 0.67 ALDH1A1 (0.38) PDK2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL18971462 0.66 SMN1; SMN2 (0.36) SMN1; SMN2KDM4EACACBALDH1A1HSD17B10
SCHEMBL18495603 0.66 PDK2 (0.64) PDK2SMN1; SMN2CYP3A4CYP2C9CYP2D6
SCHEMBL2511301 0.65 QPCT (0.39) CYP3A4CYP2C9ALDH1A1HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3856735-B1 FUSED BICYCLIC HETEROCYCLES AS THERAPEUTIC AGENTS UNIV NEW YORK (US) 2023-09-06 EP disclosed